Cargando…
Molecular Characteristics in MRI-Classified Group 1 Glioblastoma Multiforme
Glioblastoma multiforme (GBM) is a clinically and pathologically heterogeneous brain tumor. Previous studies of transcriptional profiling have revealed biologically relevant GBM subtypes associated with specific mutations and dysregulated pathways. Here, we applied a modified proteome to uncover abn...
Autores principales: | Haskins, William E., Zablotsky, Bethany L., Foret, Michael R., Ihrie, Rebecca A., Alvarez-Buylla, Arturo, Eisenman, Robert N., Berger, Mitchel S., Lin, Chin-Hsing Annie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708153/ https://www.ncbi.nlm.nih.gov/pubmed/23875172 http://dx.doi.org/10.3389/fonc.2013.00182 |
Ejemplares similares
-
Immunotherapy and Epigenetic Pathway Modulation in Glioblastoma Multiforme
por: Chin, Christopher, et al.
Publicado: (2018) -
Prediction of BRAF mutation status in glioblastoma multiforme by preoperative ring enhancement appearances on MRI
por: Cai, Xiaomin, et al.
Publicado: (2022) -
MRI radiomic features of peritumoral edema may predict the recurrence sites of glioblastoma multiforme
por: Long, Hao, et al.
Publicado: (2023) -
Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
por: Taylor, Olivia G., et al.
Publicado: (2019) -
Cytomegalovirus as a Novel Target for Immunotherapy of Glioblastoma Multiforme
por: Schuessler, Andrea, et al.
Publicado: (2014)